Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer

17 Feb 2016

Abstract excerpt

Non-small cell lung cancer (NSCLC), caused by various mutations in a spectrum of cancer driver genes, may have distinct pathological characteristics and drug responses. Extensive genetic screening and pathological characterization is required for the design of customized therapies to improve patient outcomes. Notably, NSCLC in never-smokers exhibits distinctive clinicopathological features, which are frequently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Colorectal Cancer Treatments and Studies
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27073482
DOI: 10.3892/ol.2016.4235

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancerPMID 27073482Read ↗

Proportion and clinical features of never-smokers with non-small cell lung cancer.Semantic proximity Read ↗

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.Semantic proximity Read ↗

Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.Semantic proximity Read ↗

Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR.Semantic proximity Read ↗

Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers.Semantic proximity Read ↗

Differences in EGFR and KRAS mutation spectra in lung adenocarcinoma of never and heavy smokersSemantic proximity Read ↗

Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status.Semantic proximity Read ↗

Genetic and Biochemical Alterations in Non-Small Cell Lung CancerSemantic proximity Read ↗

Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern SwitzerlandSemantic proximity Read ↗

Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.Semantic proximity Read ↗

Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers.Semantic proximity Read ↗

Dearth of smoking-induced mutations in NSRO-driven non-small-cell lung cancer despite smoking exposureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.